Showing results (171-180 of 8,763) with videos related to
Sort By:
Pageof 877
Pediatric Blood & Cancer|January 13, 2012
Feasibility of neurobehavioral screening following diagnosis of pediatric cancerLaura P Pejnovic, Cinzia R De Luca, Ellen Gentle, et al.Pediatric Blood & Cancer|January 13, 2012
Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registrySofia Mouttalib, Henry E Rice, Denise Snyder, et al.Pediatric Blood & Cancer|January 31, 2012
What is the evidence for radical surgery in the management of localized embryonal bladder/prostate rhabdomyosarcoma?Nicholas Alexander, Sheila Lane, Rowena HitchcockPediatric Blood & Cancer|February 15, 2012
The management of menstrual suppression and uterine bleeding: a survey of current practices in the Pediatric Blood and Marrow Transplant ConsortiumEnitan A Adegite, Rakesh K Goyal, Pamela J Murray, et al.Pediatric Blood & Cancer|March 17, 2012
Ambulatory care connections of Medicaid-insured children with sickle cell diseaseDavid G Bundy, John Muschelli, Gwendolyn D Clemens, et al.Pediatric Blood & Cancer|March 2, 2012
Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemiaMaynika V Rastogi, Linda Stork, Brian Druker, et al.Pediatric Blood & Cancer|August 30, 2008
Response to mercaptopurine for refractory autoimmune cytopenias in childrenAmy Sobota, Ellis J Neufeld, Sameer Lapsia, et al.Pediatric Blood & Cancer|September 20, 2008
Identification of a novel mutation in DKC1 in dyskeratosis congenitaMaria Kurnikova, Irina Shagina, Lilia Khachatryan, et al.Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.Pediatric Blood & Cancer|July 29, 2008
A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disordersTomonobu Sato, Ryoji Kobayashi, Kazue Yasuda, et al.Pageof 877